Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|February 24, 2016
[A Case with Multiple Comorbidities of Obsessive-Compulsive and Related Disorders]Ayako Arikawa, Hironori Mito, Mikuni Motoyama, et al.
Psychiatry and Clinical Neurosciences|March 17, 2007
Secondary obsessive-compulsive disorder related to diaschisis after pontine infarction, successfully treated with paroxetineTokuzo Matsui, Sanjaya Saxena, Joji Kawabe, et al.
International Journal of Molecular Sciences|December 23, 2023
Molecular Mechanisms of IL18 in DiseaseKyosuke Yamanishi, Masaki Hata, Naomi Gamachi, et al.
Psychiatry Research|March 31, 2026
Effectiveness of low-intensity cognitive-behavioral therapy for obsessive-compulsive disorder in routine psychiatric practiceKeiichiro Mukai, Yukihiko Hosoi, Kyosuke Yamanishi, et al.
Psychiatry and Clinical Neurosciences|June 21, 2011
Correlations between the offensive subtype of social anxiety disorder and personality disordersToshihiko Nagata, Hisato Matsunaga, Irene van Vliet, et al.
BMC Psychiatry|February 13, 2025
Clinical characteristics and treatment response of a possible self-contamination subtype of obsessive-compulsive disorder: a prospective investigationKeiichiro Mukai, Kyosuke Yamanishi, Yukihiko Hosoi, et al.
Psychiatry and Clinical Neurosciences|April 14, 2018
Ten-year follow-up study of Japanese patients with obsessive-compulsive disorderAkihiro Nakajima, Naomi Matsuura, Keiichiro Mukai, et al.
Psychiatry and Clinical Neurosciences|February 5, 2021
Evaluation of hemodynamic changes using near-infrared spectroscopy in patients with tic-related obsessive-compulsive disorderKeiichiro Mukai, Naomi Matsuura, Masahiro Miyauchi, et al.
Current Psychiatry Reports|April 25, 2012
A 2012 evidence-based algorithm for the pharmacotherapy for obsessive-compulsive disorderDan J Stein, Nastassja Koen, Naomi Fineberg, et al.
International Journal of Psychiatry in Clinical Practice|June 19, 2014
A benzisothiazole derivative and antipsychotic agent, perospirone, for augmentation of selective serotonin reuptake inhibitors (SSRIs) in refractory obsessive-compulsive disorder (OCD): two patient case seriesHisato Matsunaga, Tokuzo Matsui, Kenzo Ohya, et al.
Pageof 6